![Shuang Yang, Scientist, China](/optim/dotcom/content-app/events/quaterly-results/2024/2024-q2-2024-results/Hero-Banner-Q2-Results.jpg?size=orig)
Second quarter 2024 results
Second quarter 2024 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.
Thursday July 25, 2024
14:30 - 16:00 CET (8:30am – 10am EST)
Upcoming events
15Aug
2024
TD Cowen Hot Wheels Bus Tour
11:45 - 12:45 EST
Broker Conference
4Sep
2024
J.P. Morgan European Healthcare CEO Call Series
15:00 - 16:00 CEST
Broker Conference
6Sep
2024
Morgan Stanley 22nd Annual Global Healthcare Conference
08:30 - 14:00 EST
Broker Conference
Press releases
July 25, 2024
Press Release: Online availability of Sanofi’s half-year financial report for 2024
July 25, 2024
Press Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded
July 17, 2024
Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A
![Dr. Lingaraju checks the health of Manikantan as his sister Geetha watches closely inside the Billigiri Ranganathaswamy Temple Tiger Reserve in Chamrajanagara district, Karnataka state, India](/optim/dotcom/pages/images/investor-relations/environnement-social-gouvernance/herobanner-esg_20230523092330.jpg?size=large)
Environment, Social, Governance
As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.
![](/optim/dotcom/pages/images/investor-relations/202303-RD-Belgium-Nils-Libert-Sanofi-02-SimonBuxton_20240604075354.jpg?size=large)
Contact Our Investor Relations Team
To join the Sanofi front desk,
Please contact the Global Headquarters in France :
+33 (0)1 53 77 40 00
To contact the Investor Relations team:
46 avenue de la Grande Armée
75017 Paris FRANCE
investor.relations (at) sanofi.com